BioSpace's List of May 2019 Life Science IPOs

May 2019 IPO Filings and Pricings, Updated 5/23/19

Know of an IPO since May 1, 2019, that we missed? Email us at  

Related: Check out BioSpace's January list, February list, March list, and April list. 

Date Company Name Amount (USD) Company HQ Research Focus
5/22/19 Bicycle Therapeutics $60.6M Priced Cambridge, UK Exosome therapeutics in I/O and infectious diseases
5/22/19 Biophytis $15M Filed Paris, France Novel therapeutics that slow down the degenerative processes associated with aging
5/13/19 Applied Therapeutics $40M Priced New York City, NY Cutting-edge technology to validated drug targets in areas of high unmet medical need
5/8/19 Axcella $71.4M Priced Cambridge, MA AXA Development Platform to harness power of endogenous metabolic modulators (EMMS)
5/8/19 Milestone Pharmaceuticals $82.5M Priced Montreal, Quebec, Canada Developing and commercializing etripamil for the treatment of cardiovascular indications
5/8/19 NextCure $75M Priced Beltsville, MD Immunomedicines to treat cancer and other immune-related diseases
5/8/19 Cortexyme $75M Priced South San Francisco, CA Novel treatments for altering the course of neurodegenerative diseases
5/7/19 Trevi Therapeutics $55M Priced New Haven, CT Nalbuphine ER to treat serious neurologically mediated conditions
5/2/19 TransMedics $91.1M Priced Andover, MA Organ transplant therapy for end-stage organ failure patients across multiple disease states









Back to news